NR1I2 and metabolic dysfunction-associated steatotic liver disease: Besides promoting the development of NAFLD, the activation of PXR by PCN has also been demonstrated to enhance atherosclerosis formation in Apoe−/− mice, which is in line with its observed effects on the atherogenic VLDL and LDL levels [79].